Factors Associated With MOG‐IgG Serostatus Change

ABSTRACT Neurologists often re‐test MOG‐IgG, but the frequency and factors associated with serostatus change are unknown. We examined this issue in a clinical cohort of patients serially tested for MOG‐IgG at Cleveland Clinic between 2017 and 2025. Kaplan–Meier curves estimated seroconversion/seroreversion‐free probability. Of 272 with serial testing, 16 seroreverted (to negative), 4 seroconverted (to positive). At 1 year, seroreversion‐free probability was 85% (95% CI: 76%, 96%) and seroconversion‐free probability was 98% (95% CI: 95%, 100%). Seroreversion occurred in 16 of 59 (27%), of whom 11 had titers < 1:100; none had further relapses. Seroconversion was uncommon (< 2%) and occurred in patients with steroid treatment at initial testing.

Authors

Institutions

Publication Details

Journal
Annals of Clinical and Translational Neurology
Published
2026-11-14
DOI
https://doi.org/10.1002/acn3.70551
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Factors Associated With MOG‐IgG Serostatus Change

Amy C. Kunchok, Jeffrey Allen Cohen, Mengke Du, Katherine Havard‐Coiro
Annals of Clinical and Translational Neurology
Multiple Sclerosis Research Studies
article

Factors Associated With MOG‐IgG Serostatus Change

Amy C. Kunchok, Jeffrey Allen Cohen, Mengke Du, Katherine Havard‐Coiro
article en

Abstract

ABSTRACT Neurologists often re‐test MOG‐IgG, but the frequency and factors associated with serostatus change are unknown. We examined this issue in a clinical cohort of patients serially tested for MOG‐IgG at Cleveland Clinic between 2017 and 2025. Kaplan–Meier curves estimated seroconversion/seroreversion‐free probability. Of 272 with serial testing, 16 seroreverted (to negative), 4 seroconverted (to positive). At 1 year, seroreversion‐free probability was 85% (95% CI: 76%, 96%) and seroconversion‐free probability was 98% (95% CI: 95%, 100%). Seroreversion occurred in 16 of 59 (27%), of whom 11 had titers < 1:100; none had further relapses. Seroconversion was uncommon (< 2%) and occurred in patients with steroid treatment at initial testing.

Annals of Clinical and Translational Neurology
Cleveland Clinic (US)
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon